Introduction
Chagas' disease, the chronic parasitic disease whose etiolog-
The infection is disseminated to internal organs via the bloodstream. After invading nucleated host cells, the parasites ical agent is the protozoan Trypanosoma cruzi, affects~16 million people in Latin America (1). The infective forms (tryporapidly escape from the parasitophorous vacuoles and transform into amastigotes upon entry in the cytosol. Several cycles mastigotes) are transmitted to mammals by blood-sucking triatomine insects or by transfusion of contaminated blood.
of binary division occur before the amastigotes transform
Correspondence to: J. Scharfstein
Transmitting editor: V. Nussenzweiginto infective trypomastigotes (2); the intracellular cycle is displayed on GP25, CD4 ϩ T cells from Chagas' disease patients (CDP) recognize epitopes present in the catalytic terminated when the heavily parasitized host cells burst, releasing trypomastigotes and amastigotes to the extracellular domain (25) . In addition to the antigenic properties, the cruzipains are space. The manifestations resulting from acute disease (e.g. high blood parasitemia) subside with the onset of acquired enzymatically stable and active within a broad range of pH (21) , and thus may possibly act as extracellular proteinases. immunity, but the parasites are not completely eradicated: a low grade and fluctuating parasitemia is the only direct Interstitial spaces might be exposed to active forms of cruzipains that were either secreted or leaked by amastigotes, as detectable trait of an otherwise latent infection that remains asymptomatic for many years in most immunocompetent these organisms extravasate from collapsed myofibers. Of further interest to molecular pathogenesis mechanisms, we patients (3). Cellular immunity was implicated in acquired resistance in mice (4-6), yet there is also evidence that CD4 ϩ have recently found that these functionally diverse proteinases can (i) degrade several components of the extracellular matrix effector T h 1 cells are down-regulated by T h 2 cytokines (7), presumably sparing host tissues from excessive tissue damin vitro (Del Nery et al., unpublished observations) and (ii) act as kinin-releasing enzymes (kininogenase) (Del Nery et al., age. Deficits in IL-2 function (8, 9) and T cell apoptosis (10) may also account for the equilibrium in the host-parasite submitted). Although the activity of cruzipain in vitro decays slowly due to oxidative inactivation of the active-site cysteine, relationship. In mice, the acute infection induces a massive polyclonal activation of B/T lymphocytes (11) , but the relationits inactivation in vivo is likely accelerated by interactions with host protease inhibitors, such as α 2 -macroglobulin (α 2 M) or ship, if any, of these early immunoregulatory abnormalities with the development of chronic pathology in humans is still with proteins from the cystatin superfamily (33). The tetrameric α 2 M inhibits a wide spectrum of host proteinases by way of obscure (3, [12] [13] [14] .
The mechanisms responsible for chronic myocardial an entrapment mechanism (34); the inhibitor's bait region is cleaved by the target enzyme, this process resulting in inflammation are still a matter of controversy (3, 13, 14) . Admittedly, autoimmune mechanisms may account for the presence the exposure of receptor-binding sites on bound α 2 M. The entrapped proteinase can be efficiently cleared from body of prominent mononuclear cell infiltrates in myocardial sections that usually show a paucity of T. cruzi organisms (12- fluids by α 2 MR/LRP (CD91 ϩ ), a multi-ligand receptor (35, 36) whose expression in the blood is restricted to monocytes 14). The recent isolation of CD4 ϩ T cell clones to self-myosin from heart specimens of patients with severe chronic chagasic (37) . By analogy to antigen-specific Ig receptors on B cells (38), this scavenger receptor can mediate the adsorptive myocardiopathy (CCM) (15) offers circumstantial support to this concept. Other authors (16) have proposed that infectionuptake of model antigens (e.g. hen egg lysozyme) bound to α 2 M by mouse macrophages, this process being accompanassociated events (hence mediated by parasites) progressively impair the cardiac microvasculature, the interstitial ied by a marked decrease in the threshold of activation of T cell hybridomas (39) . In the present study, we sought to fibrosis being precipitated and/or aggravated by converging immunopathological processes. As more sensitive histochemdetermine if similar pathways could potentiate human CD4 ϩ T cell responses to a proteinase antigen derived from a ical techniques were applied in the analysis of myocardial specimens, it became apparent that the parasite load was pathogenic parasite. underestimated (17) (18) (19) . Notably, Higuchi et al. (17) found a direct correlation between the severity of mononuclear cell Methods infiltration and the load of T. cruzi antigen in endomyocardial biopsies and autopsies analyzed by immunohistochemistry.
Purified proteins and antibodies More recently, the use of magnetic resonance imaging with Cruzipain (GP57/51) was purified from T. cruzi epimastigotes gadolinium enhancement to guide endomyocardial and (Dm28c clone), as described by Lima et al. (40) . Human surgical biopsies have further validated their conclusions α 2 M was isolated according to established procedures (41) . (18) . Using PCR amplification methods, other groups have Human rRAP was expressed in Escherichia coli as a fusion independently demonstrated the presence of T. cruzi in protein with glutathione S-transferase and purified as sites of myocardial inflammation (19) . While not excluding a described (42). BSA and papain were purchased from Sigma secondary role for autoimmune reactions in CCM, these (St Louis, MO). mAb 8G1 (anti-α 2 MR/LRP) was obtained as studies suggest that parasite factors may be involved in the described (36). mAb 212BH6 and JO1 (IgG1) were obtained chronic inflammatory process.
from BALB/c mice immunized with purified cruzipain. Goat In this context, the pathogenic potential of the highly antibodies to human α 2 M were from Sigma. Normal goat antigenic T. cruzi cysteinyl proteinases (cruzipain, cruzain or serum was purchased from Fazenda Pigue (Rio de Janeiro, GP57/51) (20-27) is worth assessing. Encoded by Ͼ100 Brazil). Peroxidase-conjugated anti-mouse IgG was closely related and polymorphic genes (28) (29) , the cruzipains purchased from Amersham International (Amersham, UK). are expressed by all developmental forms of the parasite Anti-CD14 ϩ , CD19 ϩ , CD4 ϩ and CD8 ϩ fluoresceinated anti-(and at high levels by amastigotes) (27) . Primarily associated bodies were from Becton Dickinson (San Jose, CA). with lysosomal-like vesicles (21) , the mature forms of cruzipain(s) display a long and unique C-terminal extension (30) Preparation of cruzipain:α 2 M complexes which folds independently from the papain-like catalytic domain. The highly glycosylated C-terminal extension (31)
Cruzipain (PBS, pH 7.2) was pre-activated with 2.5 mM DTT for 45 min at 4°C. To avoid spontaneous oxidation, the active corresponds to a serodiagnostic antigen previously referred to as GP25 (23, 32) . In contrast to the antibody epitopes enzyme was rapidly loaded on a PD10 column (Pharmacia-Biotechnology, Uppsala, Sweden) pre-equilibrated with the wells, and the cultures were incubated for 1 h at 37°C, in degassed PBS, pH 7.2, supplemented with 0.25 mM DTT.
a CO 2 incubator. The internalization process was stopped by The enzyme recovered in the excluded volume remained adding 0.5% Na-azide, followed by a brief trypsinization (60 active for at least 1 h, thus allowing further manipulation of µg/ml, 5 min at room temperature) to remove surface bound the sample; at this low concentration DTT did not impair the molecules. After neutralizing trypsin with FCS (10%), the inhibitory activity of α 2 M, as measured by assays of azocasein PBMC were washed three times with RPMI-0.5% Na-azide. hydrolysis with trypsin. The incubation of active cruzipain FACS analysis was carried out after fixation of the trypsinized (205 nM for T cell assays) with α 2 M (molar ratio of 1:2) or, in PBMC with 2% paraformaldehyde for 30 min at 4°C. In a some experiments, with fresh human serum (diluted 1: 10) separate set of experiments, radioiodinated cruzipain was proceeded at 37°C for 45 min. Samples containing activeused to measure the uptake of the complexes by monocytes, site inactivated cruzipain were prepared by incubating cruziwhich were isolated from normal human blood on Percoll pain with 5 mM DTT in the presence of 100 µM of E-64 (4°C, gradients (45). Firstly, [ 125 I]cruzipain (1.45ϫ10 6 c.p.m.) was 1 h), the inhibitor being removed by dialysis against PBS.
pre-incubated with α 2 M (molar ratio 1:1) or with PBS diluent Controls using inactive forms (mα 2 M) were prepared by (as control) at 37°C for 45 min. In the meantime, half of a incubating α 2 M with methylamine (50 mM, pH 8.0) for at least monocyte suspension (2.7ϫ10 5 cells) was treated with 1 µM 3 h at 37°C. The samples containing mα 2 M or α 2 M were rRAP in RPMI/BSA (5 mg/ml), whereas the other half was subsequently dialyzed against cold PBS, pH 7.2, and, when exposed to RPMI/BSA, supplemented with an additional aliprepared for T cell assays, were concentrated and sterilized quot (1 µM) of BSA. After incubating the cells for 1 h at 37°C by filtration before mixing with sterile, pre-activated cruzipain.
in a CO 2 incubator, the reaction was terminated by the addition of 0.1% Na-azide. The monocytes were washed three Labeling procedures times (at 1200 r.p.m. for 10 min) with RPMI containing 0.1% Labeling of purified cruzipain with FITC was carried out as Na-azide at 4°C and the radioactivity was counted in a γ-described (43); FITC-cruzipain preserved its catalytic activity, counter (Beckman, Gamma 40000). as assessed by continuous kinetic assays using the fluorogenic substrate Z-F-R-MCA (40) . Tubes coated with iodogen T cell assays (Sigma) were used to radioiodinate cruzipain with 1 mCi of Peripheral blood was obtained from chronic CDP (n ϭ 13) or Na 125 I (Amersham International) for 10 min at 4°C (44) . The normal donors (n ϭ 4). Clinical and diagnostic evaluation radiolabeled cruzipain (sp. act 2.8ϫ10 6 c.p.m./µg) was stored were carried as described (46) . PBMC were obtained by at 4°C and used within 2-3 weeks. The labeled enzyme was density centrifugation through Ficoll-Paque (Pharmacia LKB checked for enzymatic activity with Z-F-R-MCA as described Biotechnology, Uppsala, Sweden). T cell assays were carried (40), using disposable cuvettes.
out as described (26) using PBMC (1.5ϫ10 5 cell/well) in 96-Immunoblotting and immunoprecipitation well flat-bottom microplates. The cells were cultivated in 200 µl of Hybri-Max medium (Sigma), 23.8 mM NaHCO 3 , Cruzipain:α 2 M complexes and control samples were boiled for supplemented with 50 µM 2-mercaptoethanol and 10% of a 5 min in SDS-sample buffer containing 5% 2-mercaptoethanol pool of heat-inactivated human AB serum, in the presence before being subjected to electrophoresis on 9% SDS-PAGE.
(or absence) of antigen (2.5 ng to 5 µg/ml of free cruzipain Blotted cruzipain antigens were identified with mAb 212BH6, or equivalent contents of cruzipain:α 2 M) or mitogen (phytothe reaction being developed by chemiluminescence hemagglutinin, 5 µg/ml), for 5 days. A modified protocol, (Amersham International) after treatment with peroxidaseusing PBMC-CDP depleted of CD19 ϩ B cells, was used to conjugated anti-mouse Ig. The formation of soluble complexes investigate the role of α 2 MR/LRP in the stimulation of T between α 2 M and [ 125 I]cruzipain was characterized by cell responses. PBMC (1ϫ10 6 /ml, whole suspension) were immunoprecipitation. The complexes were prepared by incubdepleted of B lymphocytes by incubating Pan 19 Dynal beads ating activated [ 125 I]cruzipain (0.4 µM, 1.4ϫ10 6 c.p.m.) with (ratio of 2 beads/cell) at 4°C for 30 min. These cells [PBMC(-equimolar contents of purified α 2 M or fresh human serum CD19 ϩ )] were then diluted in cold Hybri-Max medium with (diluted 1: 10 final). The labeled complexes were then precipit-1% NHS (30 ml tubes; Falcon, Corning, NY) and then exposed ated with 30% of Protein G-agarose (Gibco, Gaithersburg, to either rRAP (final concentration of 175 nM) or to PBS (as MD) that had been previously coated with excess of goat a control) for 1 h at 4°C. After seeding PBMC(-CD19 ϩ ) onto antibodies to human α 2 M or with normal goat serum as the wells (at 1ϫ10 5 cells/well), variable concentrations of controls. The precipitates were washed three times with PBS/ cruzipain antigen (enzymatically active or inactivated with ETween 0.05% containing 2 mM EDTA and solubilized by 64, and for each case, treated or not with α 2 M) or phytohemagboiling on SDS-sample buffer. Bands containing radiolabeled glutinin were added and the cultures where reconstituted with cruzipain were identified by autoradiography on Kodak Xmedium containing 10% of NHS. T cell proliferation was Omat films (Sigma). 
Immunohistochemistry
Myocardial fragments were obtained from three necropsies of individuals that had chronic cardiopathy, all of them exhibiting severe myocarditis. The sections were analyzed by the immunoperoxidase technique. The following mAb were used as primary antibodies: JO1 (IgG1, mouse) to cruzipain was used at 1:800, whereas mAb 8G1 (diluted at 1:160) was used to identify LRP/α2MR. The anti-cruzipain reaction was performed in paraffin-embedded 5 µm sections using a previously described method (16) . mAb anti-LRP/ α2MR was tested in 5 µm frozen sections that were fixed in acetone and incubated with the primary antibody overnight at 4°C. Biotinylated rabbit anti-mouse Ig (Dakopatts, Glostrup, Denmark) was used as a secondary step. The reactions were revealed with horseradish peroxidase-conjugated streptavidin. 
Results
Cruzipain was treated with α 2 M under various conditions. The samples were boiled for 5 min with SDS/5% 2-mercaptoethanol before being
Characterization of molecular complexes formed by cruzipain bands were only slightly intensified, indicating that the limited formation of covalently linked complexes was not due to suboptimal concentrations of the native active α 2 M. In parallel immunoblotting assays with antibodies to α 2 M (not shown), the high mol. wt bands were also stained, indicating that they minor fraction of cruzipain molecules. The proportion of covalently linked complexes was not increased upon further represent covalently bound complexes rather than cruzipain aggregates. It is noteworthy that the covalently linked aggregaddition of a stoichiometric excess of purified α 2 M nor by prolonging reaction time (data not shown). ates were not produced when α 2 M was incubated with cruzipain previously inactivated with E-64 (track c). Moreover, α 2 MR/LRP promotes an enhanced uptake of cruzipain:α 2 M mα 2 M (track d) failed to generate the high mol. wt bands complexes by normal PBMC observed with the native plasma protein. We then carried out immunoprecipitation analysis of the reaction mixtures Flow cytometry analysis was used to measure the cellular uptake of cruzipain-FITC (Fig. 2) . The percentage of singleprepared by incubating DTT-activated [ 125 I]cruzipain (which remained enzymatically active) and purified α 2 M, in order to positive fluoresceinated cells was almost twice as high (19.8%, Fig. 2B ) when the PBMC were incubated with α 2 M:cruzipaindetermine if some of the complexes were stabilized by reversible interactions. The radiolabeled bands that were co-FITC complexes, as compared to treatment with cruzipain-FITC alone (10.9%, Fig. 2A ). This enhancement was abrogated immunoprecipitated by antibodies to α 2 M (Fig. 1B, track d) included a major cruzipain band of~57 kDa and, in addition, by pre-treating the PBMC with 6 µM rRAP (Fig. 2C) , thus suggesting that the uptake was mediated by α 2 MR/LRP. two minor high mol. wt bands; the latter were not present in the original [ 125 I]cruzipain (track a). Importantly, the same Similar results were observed when we used monocytes isolated from normal PBMC to characterize the uptake immunoprecipitation pattern was reproduced when we substituted purified α 2 M for diluted fresh human serum (track e), dependency of radiolabeled cruzipain complexes (Table 1) . The cellular uptake was higher when the cells were treated again confirming that the covalent interactions only involve a with mα 2 M:cruzipain, indicating that the methylamine nucleophile has induced the full exposure of the cell binding sites on the plasma protein. In agreement with immunoblotting data, gel filtration experiments (data not shown) indicated that mα 2 M binds reversibly to cruzipain. A low uptake was observed when α 2 M was incubated with [ 125 I]cruzipain inactivated by E-64 (Table 1 ), suggesting that proteolysis is required to induce the exposure of receptor-binding sites on native α 2 M; the uptake of [ 125 I]cruzipain:α 2 M complexes was markedly reduced when monocytes were pre-treated with rRAP, further suggesting that the uptake is mediated by α 2 MR/LRP.
Role of α 2 MR/LPR in cruzipain presentation to T cells
To verify if receptor-mediated uptake by monocytes was accompanied by increased responsiveness of CD4 ϩ T cells, the stimulation index (SI) was determined for PBMC of 13 CDP and four normal donors. The majority of the patients (n ϭ 8) responded fairly well to cruzipain. Initially, the stimulation of PBMC-CDP with cruzipain:α 2 M or cruzipain alone yielded relatively low, yet comparable proliferative responses. We reasoned that the population of cruzipain-specific B lymphocyte antibody (IgG) was probably expanded in the PBMC-CDP, since high titers of IgG antibodies were present in the serum of these patients. To discard the potential contribution of these antigen-specific B cells as antigen-presenting cell (APC), the PBMC-CDP cells were extensively depleted (Ͻ2%) of CD19 ϩ lymphocytes [PBMC(-CD19 ϩ )] before being exposed to cruzipain, which was added alone or as equimolar cruzipain:α 2 M complexes. The T cell proliferative responses illustrated in Fig. 3(A-D) are representative of the group of cruzipain responders. In spite of the variable intensity of proliferative responses observed for each individual, higher stimulation indexes were often observed in PBMC(-CD19 ϩ ) cultures treated with cruzipain:α 2 M complexes, as compared with cruzipain alone. One of these patients responded in a Fig. 2 . Uptake of FITC-cruzipain by PBMC. PBMC isolated from similar way when tested twice (Fig. 3A versus B) , in an interval normal human blood were resuspended in RPMI/BSA and incubated of~1 year. However, the optimal concentration range of levels ( Fig. 3A-D) . The potentiating effects of cruzipain:α 2 M complexes were likely mediated by LRP/α 2 MR, because they were partially or entirely reduced upon pre-treatment of PBMC(-CD19 ϩ ) with 1 µM rRAP (Fig. 3B-D) ; in one case Table 1 . Analysis of uptake of [ 125 I]cruzipain by monocytes (Fig. 3D) , there was a small, but significant reduction of the T cell response to cruzipain alone. The inhibitory effect of rRAP CD19 ϩ ) cultures were exposed to α 2 M that had been previ- (A) cruzipain versus α2M:cruzipain at 300 ng/ml antigen, P Ͻ 0.033; at 600 ng/ml antigen, P Ͻ 0.014; (B) cruzipain versus α2M:cruzipain at 500 ng/ml antigen, P Ͻ 0.019; rRAP/ α2M:cruzipain at 500 ng/ml antigen, P Ͻ 0.026; cruzipain versus α2M:cruzipain at 1000 ng/ml antigen, P Ͻ 0.008; (C) cruzipain versus α2M:cruzipain at 700 ng/ml antigen, P Ͻ 0.001; rRAP/α2M:cruzipain at 700 ng/ml antigen, P Ͻ 0.001; (D) cruzipain versus α2M:cruzipain at 250 ng/ml antigen, P Ͻ 0.046; rRAP/α2M:cruzipain at 250 ng/ml antigen, P Ͻ 0.013; cruzipain versus α2M:cruzipain at 500 ng/ml antigen, P Ͻ 0.043; rRAP/α2M:cruzipain at 500 ng/ml antigen, P Ͻ 0.001; cruzipain versus α2M:cruzipain at 1000 ng/ml, P Ͻ 0.045; rRAP/ α2M:cruzipain at 1000 ng/ml, P Ͻ 0.008.
ger receptor, by itself, does not trigger non-specific proliferadepots appear to consist of damaged parasites. Moreover, some of the macrophage-like cells associated with the tion of T cells.
lymphohistiocytic inflammatory infiltrate also displayed Immunohistochemical evidence that cruzipain antigen and intracellular staining with mAb anti-cruzipain, possibly repres-α 2 MR/LRP (CD91 ϩ ) cells are localized in sites of chronic enting phagocytosed parasites. Interestingly, the experiments myocardial inflammation shown in Fig. 4 (B) demonstrate that part of the macrophagelike cells in the inflammatory infiltrates were imunostained by Myocardial fragments from three necropsies of individuals that had severe chronic cardiopathy were analyzed by mAb anti-α 2 MR/LRP. immunohistochemistry with mAb. In spite of the scarce distribution, infected myofibers yielded strong cytoplasmic staining Discussion with mAb anti-cruzipain, the reactivity being likely directed at intracellular amastigotes. Apart from these intracellular
In the present study we demonstrate that the interaction of α 2 M with T. cruzi cysteinyl proteinases enhanced the deposits, extracellular cruzipain antigens were also identified amidst damaged myocardial fibers, in the proximity of lymphpresentation of these parasite antigens to CD4 ϩ T cells from CDP. The inhibitory activity of rRAP on cellular uptake assays, ohistiocytic inflammatory infiltrates (Fig. 4A) . The immunostaining pattern of extracellular cruzipain was irregular and cocombined with the requirement for bait region cleavage of α 2 M, have implicated the multiligand α 2 MR/LRP receptor of localized with amastigote-like structures; part of the cruzipain monocytes in the adsorptive uptake of cruzipain, as well as cruzipain, possibly representing remnants of amastigotes that were phagocytosed, following their release into interstitial in the antigen presentation process. In spite of the variable intensity of the proliferative responses elicited by lymphocytes spaces. Interestingly, B cells are not likely acting as APC in sites of myocardial inflammation, because they are present from each patient, marked differences in the threshold of T cell activation were usually observed in cultures exposed to in very low numbers (Ͻ1% ) (52) . Presently, it is unclear if these intralesional macrophages could scavenge α 2 M:cruzipain low concentrations of cruzipain:α 2 M complexes, as compared to cruzipain alone; the effects of rRAP were specific, because complexes in the inflammatory sites. This might occur if α 2 M originating from plasma exudates or secreted by inflammatory the responses triggered by PHA mitogen or by PPD remained unaltered. In a single case, however, rRAP also reduced the macrophages (47) permeate areas of myocardium damage. Although the expression of enzymatically active forms of proliferative response stimulated by native cruzipain alone, perhaps due to the secretion of small endogenous supplies cruzipains was not directly demonstrated in situ, the finding that they are readily detected in the supernatants from amastiof α 2 M into the culture medium (47) .
Experiments performed with purified α 2 M or fresh serum gote suspensions (J. Scharfstein, data not shown) suggests that this can possibly occur in the interstitial spaces. Admithave shown that a fraction of the cruzipain molecules was irreversibly bound to the inhibitor. This heterogeneous tedly, the same mechanism may potentiate down-regulatory responses mediated by cruzipain-specific T cells from the behavior was also noted with mammalian cathepsin L, B and H (48), possibly reflecting a poor accessibility of surface-T h 2 subset, if the latter are recruited to sites of myocardial damage. Studies in experimental models are in progress to exposed lysine acceptors in some members of the papain superfamily of proteases. Along similar lines, activated α 2 M ascertain if the multifunctional T. cruzi cysteinyl proteinases play an active role in the induction and/or regulation of may only form ε-lysil-γ-glutamyl amide bonds (49) with certain subsets of cruzipain isoforms (29) . Irrespective of the molecuinflammatory responses in Chagas' heart disease. lar basis for the biochemical heterogeneity, we showed that the increased adsorptive uptake of the cruzipain complexes resulted in enhanced antigen presentation to T cells. Itinside APC vesicles. Since they originate from lysosomal-like organelles of T. cruzi (21) , cruzipains (free forms) may persist stable and enzymatically active upon delivery to acidic endosomes of APC; previous studies with MEP, a procathepsin L Abbreviations of tumor origin have shown that by-stander antigen processing infection (23, 26 the macrophage-like cells showed intracellular deposits of
